4-Methyl-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-carbaldehyde

Introduction

CAS No. :	141103-93-7	MDL No. :	MFCD02681912
Formula :	C10H11NO2	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	WJHBKMPLXRGBGM-UHFFFAOYSA-N
M.W :	177.20	Pubchem ID :	2776404
Synonyms :

Physicochemical Properties

Num. heavy atoms :	13
Num. arom. heavy atoms :	6
Fraction Csp3 :	0.3
Num. rotatable bonds :	1
Num. H-bond acceptors :	2.0
Num. H-bond donors :	0.0
Molar Refractivity :	53.35
TPSA :	29.54 Ų

Pharmacokinetics

GI absorption :	High
BBB permeant :	Yes
P-gp substrate :	No
CYP1A2 inhibitor :	Yes
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-6.49 cm/s

Lipophilicity

Log Po/w (iLOGP) :	1.73
Log Po/w (XLOGP3) :	1.25
Log Po/w (WLOGP) :	0.95
Log Po/w (MLOGP) :	0.74
Log Po/w (SILICOS-IT) :	1.84
Consensus Log Po/w :	1.3

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	1.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-2.0
Solubility :	1.77 mg/ml ; 0.00996 mol/l
Class :	Soluble
Log S (Ali) :	-1.47
Solubility :	6.02 mg/ml ; 0.034 mol/l
Class :	Very soluble
Log S (SILICOS-IT) :	-2.36
Solubility :	0.777 mg/ml ; 0.00439 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	1.0 alert
Leadlikeness :	1.0
Synthetic accessibility :	1.95

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P305+P351+P338	UN#:	N/A
Hazard Statements:	H302-H315-H319-H335	Packing Group:	N/A
GHS Pictogram:

Related View all 

• 

  Ghk-Cu

• 

  Gly-His-Lys acetate salt

• 

  N-Phenylacetyl-L-Prolylglycine ethyl ester

• 

  L-Phenylalanyl-L-isoleucine

• 

  L-Isoleucyl-L-phenylalanine

• 

  L-Ala-L-phe

• 

  L-Glutathione Reduced

• 

  L-Alanyl-L-tyrosine